These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8966136)

  • 21. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report.
    Angeles-Han S; Flynn T; Lehman T
    J Rheumatol; 2008 Sep; 35(9):1897-8. PubMed ID: 18785302
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis.
    Bloom BJ
    Arthritis Rheum; 2000 Nov; 43(11):2606-8. PubMed ID: 11083287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl.
    Nakakura H; Ashida A; Matsumura H; Murata T; Nagatoya K; Shibahara N; Inoue T; Tamai H
    Ther Apher Dial; 2009 Feb; 13(1):71-6. PubMed ID: 19379173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report.
    Kasher-Meron M; Uziel Y; Amital H
    Rheumatology (Oxford); 2009 Apr; 48(4):445-6. PubMed ID: 19164423
    [No Abstract]   [Full Text] [Related]  

  • 25. Etanercept therapy in children with juvenile rheumatoid arthritis.
    Hung JJ; Huang JL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Juvenile Still's disease: a case report of treatment with infliximab].
    Meddeb N; Rammeh N; Gandoura N; Elleuch M; Cheour E; Sahli H; Hamza S; Maalej A; Sellami S
    Therapie; 2002; 57(4):407-8. PubMed ID: 12422562
    [No Abstract]   [Full Text] [Related]  

  • 28. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis?
    Prendiville JS; Tucker LB; Cabral DA; Crawford RI
    Pediatr Dermatol; 2004; 21(5):580-8. PubMed ID: 15461768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of juvenile rheumatoid arthritis. Personal experience].
    Chiossi FM
    Minerva Pediatr; 1978 Nov; 30(22):1767-71. PubMed ID: 723821
    [No Abstract]   [Full Text] [Related]  

  • 30. [Can indomethacin prolong arthritis?].
    Savolainen A; Isomäki H
    Duodecim; 1995; 111(3):257-9. PubMed ID: 8654290
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features.
    Singh-Grewal D; Schneider R; Bayer N; Feldman BM
    Arthritis Rheum; 2006 May; 54(5):1595-601. PubMed ID: 16645998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of juvenile rheumatoid arthritis treated with thymopentin].
    Tucciarone L; Felici W; Greco L; Mechelli A
    Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.
    Spiegel LR; Schneider R; Lang BA; Birdi N; Silverman ED; Laxer RM; Stephens D; Feldman BM
    Arthritis Rheum; 2000 Nov; 43(11):2402-9. PubMed ID: 11083261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Juvenile rheumatoid arthritis. What is the optimal treatment?].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2007 Sep; 30(9):349-50. PubMed ID: 17912880
    [No Abstract]   [Full Text] [Related]  

  • 35. [Arsenal against juvenile rheumatoid arthritis. Preventing permanent damage].
    Huppertz HI
    MMW Fortschr Med; 2000 Oct; 142(40):4-6, 8. PubMed ID: 11072705
    [No Abstract]   [Full Text] [Related]  

  • 36. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.
    Verbsky JW; White AJ
    J Rheumatol; 2004 Oct; 31(10):2071-5. PubMed ID: 15468378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
    Liang TC; Yang YH; Lin YT; Chiang BL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis.
    Silverman E; Spiegel L; Hawkins D; Petty R; Goldsmith D; Schanberg L; Duffy C; Howard P; Strand V
    Arthritis Rheum; 2005 Feb; 52(2):554-62. PubMed ID: 15693001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate: more questions than answers.
    Wallace CA
    J Rheumatol; 2000 Aug; 27(8):1834-5. PubMed ID: 10955320
    [No Abstract]   [Full Text] [Related]  

  • 40. Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis.
    Mirkinson LJ; Nagle D; Kadom N; Jones OY
    J Clin Rheumatol; 2006 Apr; 12(2):83-6. PubMed ID: 16601542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.